FDA Inspection
AstraZeneca Pharmaceuticals LPFDA Inspection 1175133 - AstraZeneca Pharmaceuticals LP - July 22, 2022
Record Details
This FDA Inspection record concerns AstraZeneca Pharmaceuticals LP, with an inspection on July 22, 2022, issued by the Center for Biologics Evaluation and Research, covering biologics.
Open in Dashboard
ID · dae5e2be-5942-4a41-b4a5-3f7bf88d2245
Violation Codes3
21 CFR 211.113(b)21 CFR 211.19221 CFR 211.63
Full citation text and observation details available on the Dashboard.